RESUMO

OBJECTIVE: The aim of the study was to evaluate the efficacy of interferential current (IC) in the sexual function of women with premature ovarian insufficiency (POI) using systemic hormone therapy (HT), compared to topical estriol. METHODS: A randomized clinical trial with 40 women with POI using systemic HT, who were sexually active and referred for dyspareunia and reduction of lubrication. The women were divided into two treatment groups for 4 weeks: IC group (eight electrotherapy sessions twice a week); or E group (estriol vaginal cream, daily application, 0.5 mg/d). The Female Sexual Function Index was used to evaluate pre-/posttreatment sexual function. RESULTS: Mean age was 37.13 ±â€Š7.27 years and mean treatment time with HT was 8.20 ±â€Š8.73 years, similar data for both groups. There was an improvement in global sexual function, lubrication, and pain domains for both treatments. The differences between the pre-/posttreatment lubrication scores were respectively 0.75 ±â€Š3.31 (P = 0.014) for IC and 1.16 ±â€Š1.22 (P < 0.001) for estriol, whereas for dyspareunia the differences were 1.00 ±â€Š1.47 (P = 0.005) for IC, and 0.68 ±â€Š1.30 (P = 0.006) for estriol. There was no pre-/posttreatment difference for the desire and arousal domains. Only in the IC group did orgasm (difference 0.90 ±â€Š1.42, P = 0.010) and satisfaction improve (difference 0.70 ±â€Š1.28, P = 0.021). CONCLUSION: The use of perineal IC seems to be a new option for women with POI using systemic HT and presenting with sexual complaints, leading to an improvement in pain, lubrication, satisfaction, and orgasm.

Assuntos

RESUMO

INTRODUCTION: Women with premature ovarian failure (POF) often manifest complaints involving different aspects of sexual function (SF), regardless of using hormone therapy. SF involves a complex interaction between physical, psychological, and sociocultural aspects. There are doubts about the impact of different complaints on the global context of SF of women with POF. AIM: To evaluate the percentage of influence of each of the sexuality domains on the SF in women with POF. METHODS: Cross-sectional study with 80 women with POF, matched by age to 80 women with normal gonadal function. We evaluated SF through the "Female Sexual Function Index" (FSFI), a comparison between the POF and control groups using the Mann-Whitney test. Component exploratory factor analysis was used to assess the proportional influence of each domain on the composition of the overall SF for women in the POF group. MAIN OUTCOME MEASURES: SF was evaluated using FSFI. Exploratory Factor Analysis for components was used to evaluate the role of each domain on the SF of women with POF. RESULTS: The FSFI score was significantly worse for women with POF, with a decrease in arousal, lubrication, orgasm, satisfaction, and dyspareunia. Exploratory factor analysis of SF showed that the domain with greater influence in the SF was arousal, followed by desire, together accounting for 41% of the FSFI. The domains with less influence were dyspareunia and lubrication, which together accounted for 25% of the FSFI. CONCLUSION: Women with POF have impaired SF, determined mainly by changes in arousal and desire. Aspects related to lubrication and dyspareunia complaints have lower determination coefficient in SF. These results are important in adapting the approach of sexual disorders in this group of women.

Assuntos

RESUMO

OBJECTIVE: This study aims to compare breast density between two mammograms in women with premature ovarian failure (POF). METHODS: A cohort study evaluated 56 women with POF. Two mammograms performed at least 2 years apart were analyzed. Mammogram films were digitalized, and images were assessed using a computer-assisted method; the percentage of breast image that is radiologically dense is referred to as the percentage of mammographic density (PMD). Age at menarche, age at onset of POF, length of POF, length of estrogen-progestin therapy (EPT), body mass index (BMI), pregnancy, and age at the time of each mammogram were evaluated. RESULTS: The mean (SD) age at POF diagnosis was 32.35 (5.95) years. In the first mammogram, the mean (SD) age, BMI, and length of POF were 37.58 (3.72) years, 26.79 (4.86) kg/m, and 5.25 (4.61) years, respectively. EPT had been used for a mean (SD) of 2.71 (3.12) years. In the second mammogram, the mean (SD) age, BMI, and length of POF were 43.23 (4.98) years, 27.6 (5.39) kg/m, and 10.5 (5.11) years, respectively. EPT had been used for a mean (SD) of 7.25 (4.6) years. The mean (SD) interval between mammograms was 5.25 (3) years, and the mean (SD) PMD decreased from 27.78% (21.04%) to 17.53% (15.71%) (P = 0.007). Comparing PMD between women taking EPT and those not taking EPT, we observed no significant differences. In both instances, multiparous women had lower PMD than nulliparous women (P < 0.05). BMI, length of POF, and pregnancy were negatively correlated with PMD. CONCLUSIONS: Breast density in young women with POF decreases across a period of 5 years, regardless of EPT use. Further studies may elucidate how this result will correlate with decision-making in clinical therapeutics and breast cancer risk in POF.

Assuntos

RESUMO

Este estudo faz uma revisão atualizada da prevalência do Trichomonas vaginalis na população geral, bem como sua complexa interação com o hospedeiro e as consequências da infecção não diagnosticada. O Trichomonas vaginalis é um parasita extracelular das mucosas, especialmente a vaginal, que causam descarga vaginal, irritação e inflamação, podendo ser assintomático em quase 1/3 dos casos. Atualmente tem sido pouco encontrado em alguns centros, mas continua como causa importante de vulvovaginites no mundo, mantendo-se com taxas de 10% dos corrimentos vaginais em vários estudos epidemiológicos. É abordada a complexa relação parasita-hospedeiro, em que a resposta imunológica predispõe vaginose bacteriana e infecção pelo HIV, por mobilização das células de defesa (leucócitos, linfócitos T CD4 e macrófagos). As formas de diagnóstico são apontadas para facilitar a compreensão do diagnóstico. Foram apontadas ainda as formas de tratamento e em especial as dificuldades com casos de resistência medicamentosa.

This study is an updated review of Trichomonas vaginalis prevalence in the general population as well as its complex interaction with the host and the consequences of undiagnosed infection. The Trichomonas vaginalis is an extracellular parasite of the mucous membranes, especially the vagina, causing vaginal discharge, irritation and inflammation and may be asymptomatic in nearly one third of cases. Currently, little has been found in some centers, but remains a important cause of vulvovaginitis in the world keeping up with rates of 10% of vaginal discharge in several epidemiological studies. This involves complex host parasite relationship where the immune response predisposes to bacterial vaginosis and HIV infection by mobilizing defense cells (leukocytes, CD4 T lymphocytes and macrophages). The forms of diagnosis are pointed to facilitate understanding of the diagnosis. We also pointed the way to treatment and in particular the difficulties with cases of drug resistance.

Assuntos

Assuntos

RESUMO

BACKGROUND: Papillary squamous cell carcioma is rare form of squamous cell carcinoma of the uterine cervix occurring in women in the sixth decade of life and is frequently misdiagnosed as high-grade intraepithelial lesion. Few reports with cytologic study have been performed, especially with cytology in liquid-based specimens. CASE: A 58-year-old woman who had 8 gestations (no abortions) and mitral cardiopathy treated with coumarin medication was referred for transvaginal bleeding of 20 days' duration. Specular examination showed an exophytic, easily bleeding lesion occupying all of the uterine cervix and superior third of the vagina. Liquid-based cytology showed squamous cells, mostly basaloid but some bizarre or in fiber, with clearly atypical nuclei. Second-generation hybrid capture for high-risk human papillomavirus was positive, with a viral load of 404 relative light unit/positive control B, and the tumor expressed p16(INK4a). CONCLUSION: This report adds further experience with liquid-based cytology to the existing conventional and liquid-based cytologic findings, particularly in the Brazilian female population.

Assuntos

RESUMO

OBJECTIVE: To determine the frequency of anal squamous intra-epithelial lesions (ASIL) in women with genital squamous intra-epithelial lesions (GSIL). STUDY DESIGN: In a cross sectional study, 184 patients with histopathological diagnosis of GSIL and 76 controls without GSIL, were submitted to anuscopy in order to determine the presence of ASIL. All the women were HIV-negative with anal aceto-white lesions were biopsed for histological diagnosis. RESULTS: The frequency of ASIL was 17.4% in the GSIL group (3.2% high grade ASIL) and only 2.6% in the control group (0% high grade ASIL) (p<0.001). All the high grade ASIL diagnoses were found in women with cervical SIL. CONCLUSION: Women presenting GSIL have high prevalence of ASIL.

Assuntos

Assuntos

Assuntos

RESUMO

A candidíase vaginal representa uma das ginecopatias mais frequentes, acometendo, pelo menos uma vez na vida, cerca de 75 da população feminina sexualmente ativa. Apesar de sua alta frequência, existem outras doenças vulvovaginais que mimetizam a candidíase vaginal, dificultando o diagnóstico e induzindo a tratamentos inadequados. A candidíase vulvovaginal pode assumir a forma recorrente quando se faz presente por três ou mais episódios agudos no decorrer do período de um ano, desde que apropriadamente diagnosticados (através de exames clínico e microbiológico) e tratados. Este artigo se propõe a revisar os principais tópicos referentes à identificação do fungo, sinais e sintomas, resposta imune vaginal para Candida sp, ação do sêmen sobre a imunidade vaginal, possíveis interferências genéticas e as estratégias de tratamento nos quadros recorrentes. Os autores levam em consideração que habitualmente não existe uma relação direta entre a concentração da cândida na vagina e a expressão dos sintomas clínicos. Outro aspecto considerado é que a maioria das mulheres rotuladas como portadoras de candidíase vulvovaginal recorrente não tem evidência bacterioscópica do fungo na vagina e que essa doença não pode ser distinguida de outras pela sintomatologia.

Assuntos